Ligand · 6M5
6M5 · (4~{A}~{S},8~{A}~{R})-2-cycloheptyl-4-[4-methoxy-3-[4-[4-(1~{H}-1,2,3,4-tetrazol-5-yl) phenoxy]butoxy]phenyl]-4~{A},5,8,8~{A}-tetrahydrophthalazin-1-one
6M5, (4~{A}~{S},8~{A}~{R})-2-cycloheptyl-4-[4-methoxy-3-[4-[4-(1~{H}-1,2,3,4-tetrazol-5-yl) phenoxy]butoxy]phenyl]-4~{A},5,8,8~{A}-tetrahydrophthalazin-1-one (C33 H40 N6 O4, 584.7 g/mol), in the MolNFT structures on GenesisL1: bound in 3…
- Component
- 6M5
- Formula
- C33 H40 N6 O4
- Class
- ligand
- Structures
- 3
- PDB entries
- 2
Binding sites
6M5 in 3 structures; the first of them:
- 5LAQ · Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001 · 6M5 A1005 · binds MET519, ASP564, LEU565, ASN567, TRP578, THR579, ILE582, MET583 and 7 more
- 5LAQ · Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor npd-001 · 6M5 A1005 · binds MET519, ASP564, LEU565, ASN567, TRP578, THR579, ILE582, MET583 and 7 more
- 5LBO · Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor npd-001 · 6M5 A1011 · binds TYR159, HIS160, MET273, ASP318, LEU319, ASN321, THR333, ILE336 and 8 more
Residues it binds most
MET 6, ILE 6, TYR 6, PHE 6, ASN 6, ASP 6, GLN 6, GLY 6, LEU 6, SER 6 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.